These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 21538846)

  • 21. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
    Shimizu M; Deguchi A; Joe AK; Mckoy JF; Moriwaki H; Weinstein IB
    J Exp Ther Oncol; 2005; 5(1):69-78. PubMed ID: 16416603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.
    Shimizu M; Sakai H; Shirakami Y; Yasuda Y; Kubota M; Terakura D; Baba A; Ohno T; Hara Y; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2011 Mar; 4(3):396-403. PubMed ID: 21372039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells.
    Pianetti S; Guo S; Kavanagh KT; Sonenshein GE
    Cancer Res; 2002 Feb; 62(3):652-5. PubMed ID: 11830514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor.
    Van Aller GS; Carson JD; Tang W; Peng H; Zhao L; Copeland RA; Tummino PJ; Luo L
    Biochem Biophys Res Commun; 2011 Mar; 406(2):194-9. PubMed ID: 21300025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
    Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
    Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells.
    Syed DN; Afaq F; Kweon MH; Hadi N; Bhatia N; Spiegelman VS; Mukhtar H
    Oncogene; 2007 Feb; 26(5):673-82. PubMed ID: 16862172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological effects of green tea on the gastrointestinal system.
    Koo MW; Cho CH
    Eur J Pharmacol; 2004 Oct; 500(1-3):177-85. PubMed ID: 15464031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.
    Zaveri NT
    Life Sci; 2006 Mar; 78(18):2073-80. PubMed ID: 16445946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
    Kim M; Murakami A; Kawabata K; Ohigashi H
    Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.
    J Cell Biochem Suppl; 1996; 26():236-57. PubMed ID: 9154181
    [No Abstract]   [Full Text] [Related]  

  • 34. Modulation of signal transduction by tea catechins and related phytochemicals.
    Shimizu M; Weinstein IB
    Mutat Res; 2005 Dec; 591(1-2):147-60. PubMed ID: 15992833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic issues concerning cancer prevention by tea catechins.
    Yang CS; Wang H
    Mol Nutr Food Res; 2011 Jun; 55(6):819-31. PubMed ID: 21538856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase Cδ and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells.
    Tsukamoto S; Hirotsu K; Kumazoe M; Goto Y; Sugihara K; Suda T; Tsurudome Y; Suzuki T; Yamashita S; Kim Y; Huang Y; Yamada K; Tachibana H
    Biochem J; 2012 Apr; 443(2):525-34. PubMed ID: 22257159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Green tea polyphenols: biology and therapeutic implications in cancer.
    Shankar S; Ganapathy S; Srivastava RK
    Front Biosci; 2007 Sep; 12():4881-99. PubMed ID: 17569617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
    Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
    Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemopreventive potential of green tea catechins in hepatocellular carcinoma.
    Shimizu M; Shirakami Y; Sakai H; Kubota M; Kochi T; Ideta T; Miyazaki T; Moriwaki H
    Int J Mol Sci; 2015 Mar; 16(3):6124-39. PubMed ID: 25789501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate.
    Chen L; Zhang HY
    Molecules; 2007 May; 12(5):946-57. PubMed ID: 17873830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.